Cargando…

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

During the last three decades, an increasing understanding of the etiology, psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in addition to the introduction of second-generation antipsychotics, has optimized the potential for recovery from the illness. Continued deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Wai Tong, Yip, Annie LK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775702/
https://www.ncbi.nlm.nih.gov/pubmed/24049446
http://dx.doi.org/10.2147/NDT.S37485
_version_ 1782477405614505984
author Chien, Wai Tong
Yip, Annie LK
author_facet Chien, Wai Tong
Yip, Annie LK
author_sort Chien, Wai Tong
collection PubMed
description During the last three decades, an increasing understanding of the etiology, psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in addition to the introduction of second-generation antipsychotics, has optimized the potential for recovery from the illness. Continued development of various models of psychosocial intervention promotes the goal of schizophrenia treatment from one of symptom control and social adaptation to an optimal restoration of functioning and/or recovery. However, it is still questionable whether these new treatment approaches can address the patients’ needs for treatment and services and contribute to better patient outcomes. This article provides an overview of different treatment approaches currently used in schizophrenia spectrum disorders to address complex health problems and a wide range of abnormalities and impairments resulting from the illness. There are different treatment strategies and targets for patients at different stages of the illness, ranging from prophylactic antipsychotics and cognitive–behavioral therapy in the premorbid stage to various psychosocial interventions in addition to antipsychotics for relapse prevention and rehabilitation in the later stages of the illness. The use of antipsychotics alone as the main treatment modality may be limited not only in being unable to tackle the frequently occurring negative symptoms and cognitive impairments but also in producing a wide variety of adverse effects to the body or organ functioning. Because of varied pharmacokinetics and treatment responsiveness across agents, the medication regimen should be determined on an individual basis to ensure an optimal effect in its long-term use. This review also highlights that the recent practice guidelines and standards have recommended that a combination of treatment modalities be adopted to meet the complex health needs of people with schizophrenia spectrum disorders. In view of the heterogeneity of the risk factors and the illness progression of individual patients, the use of multifaceted illness management programs consisting of different combinations of physical, psychological, and social interventions might be efficient and effective in improving recovery.
format Online
Article
Text
id pubmed-3775702
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37757022013-09-18 Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments Chien, Wai Tong Yip, Annie LK Neuropsychiatr Dis Treat Review During the last three decades, an increasing understanding of the etiology, psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in addition to the introduction of second-generation antipsychotics, has optimized the potential for recovery from the illness. Continued development of various models of psychosocial intervention promotes the goal of schizophrenia treatment from one of symptom control and social adaptation to an optimal restoration of functioning and/or recovery. However, it is still questionable whether these new treatment approaches can address the patients’ needs for treatment and services and contribute to better patient outcomes. This article provides an overview of different treatment approaches currently used in schizophrenia spectrum disorders to address complex health problems and a wide range of abnormalities and impairments resulting from the illness. There are different treatment strategies and targets for patients at different stages of the illness, ranging from prophylactic antipsychotics and cognitive–behavioral therapy in the premorbid stage to various psychosocial interventions in addition to antipsychotics for relapse prevention and rehabilitation in the later stages of the illness. The use of antipsychotics alone as the main treatment modality may be limited not only in being unable to tackle the frequently occurring negative symptoms and cognitive impairments but also in producing a wide variety of adverse effects to the body or organ functioning. Because of varied pharmacokinetics and treatment responsiveness across agents, the medication regimen should be determined on an individual basis to ensure an optimal effect in its long-term use. This review also highlights that the recent practice guidelines and standards have recommended that a combination of treatment modalities be adopted to meet the complex health needs of people with schizophrenia spectrum disorders. In view of the heterogeneity of the risk factors and the illness progression of individual patients, the use of multifaceted illness management programs consisting of different combinations of physical, psychological, and social interventions might be efficient and effective in improving recovery. Dove Medical Press 2013 2013-09-11 /pmc/articles/PMC3775702/ /pubmed/24049446 http://dx.doi.org/10.2147/NDT.S37485 Text en © 2013 Chien and Yip. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Review
Chien, Wai Tong
Yip, Annie LK
Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title_full Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title_fullStr Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title_full_unstemmed Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title_short Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
title_sort current approaches to treatments for schizophrenia spectrum disorders, part i: an overview and medical treatments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775702/
https://www.ncbi.nlm.nih.gov/pubmed/24049446
http://dx.doi.org/10.2147/NDT.S37485
work_keys_str_mv AT chienwaitong currentapproachestotreatmentsforschizophreniaspectrumdisorderspartianoverviewandmedicaltreatments
AT yipannielk currentapproachestotreatmentsforschizophreniaspectrumdisorderspartianoverviewandmedicaltreatments